
Gilles Salles, MD, PhD
Lymphoma Specialist & Cellular Therapist
Titles
Chief, Lymphoma Service, Steven A. Greenberg Chair
Clinical Expertise
Hodgkin and non-Hodgkin Lymphomas: Follicular Lymphoma, Diffuse Large B Cell Lymphoma, MALT and Marginal Zone Lymphoma; Immunotherapy for Lymphoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Salles accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-4153 Office Phone
- Speaks English and French

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University Claude Bernard, Lyon France; PhD, University Claude Bernard, Lyon France
Residencies
Internal Medicine, Lyon University Hospitals (1984-1989)
Fellowships
Hemato-Oncology, Lyon University Hospital - clinical; Harvard Medical School - research
Board Certifications
Internal Medicine, French Board of Physicians (1989); Oncology, French Board of Physicians (1992)
I am a medical oncologist devoted to caring for people with hematologic cancers, including lymphoma and chronic lymphocytic leukemia. While I have broad experience in all subtypes of lymphoma, I have a particular expertise in treating diffuse large B-cell, follicular, and other B-cell lymphoma.
After 35 years of practice, I continue to be impressed by patients as they courageously fight these diseases. I value the exchanges I have with my patients and their families and take the time to answer their questions and explain the latest advances available to help manage their illness. These include immunotherapy, targeted therapy, chemotherapy and radiation therapy.
Read more
As a member of MSK’s Lymphoma Service Disease Management Team, I work closely with colleagues in other disciplines to formulate the best possible treatment plan that meets the specific needs of each patient.
I see patients in Manhattan at MSK Koch, which offers nearly every aspect of outpatient cancer care across many specialties, so most patients can get all their treatments in one place. The state-of-the-art facility was designed to help restore patients’ health and well-being.
My passion for hematology oncology emerged during my residency. I was drawn to the dual challenge of bringing faster scientific progress to people suffering from cancer and providing medical care for those patients over the entire course of their disease. As my career became deeply focused on lymphoma, I have been fortunate to see major improvements in diagnosis and treatment achieved over the last three decades.
It has been gratifying to be personally involved in some of these advances. For example, in recent years, I contributed to the development of immunotherapies (such as monoclonal antibodies and CAR T cell therapy) for people with B cell lymphoma.
I continue to be dedicated to various aspects of clinical research, including large studies that aim to establish the best standards of care and trials that are evaluating the safety and effectiveness of new treatments that may ultimately lead to new drug approvals. When our research staff determines that a patient is eligible to enroll in one of our clinical studies, we offer that individual the opportunity to participate as part of their care plan.
I moved to New York from Lyon, France with my wife in 2020 to join MSK as Chief of the Lymphoma Service. She and I enjoy listening to live music in our spare time and we are excited about getting into the jazz music scene in the city. It’s such a pleasure when we come across talented musicians during our walks through Central Park.
Awards and Honors
- Jose Carreras Award, European Hematology Association (2020)
- Steven Greenberg Chair at Memorial Sloan Kettering Cancer Center (2021)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Salles
- A Phase IB/III Study of Lenalidomide and Rituximab plus Tazemetostat or Placebo in Patients with Recurrent or Persistent Follicular Lymphoma
- Clinical Trials Co-Investigated by Dr. Salles
- A Phase 2 Study of Tafasitamab and Lenalidomide in People with Recurrent or Persistent Mantle Cell Lymphoma
- A Phase I Study of RO7443904 in Combination with Glofitamab for People with Non-Hodgkin Lymphoma
- A Phase IA/IB Study of TTI-622 Immunotherapy in Patients with Advanced Persistent or Recurrent Blood Cancers
Read more
- A Phase II Study of Glofitamab Immunotherapy plus R-CHOP for People with Diffuse Large B-Cell Lymphoma
- A Phase II Study of Mosunetuzumab as Initial Chemotherapy-Free Treatment for Follicular Lymphoma
- A Phase III Study of LOXO-305 versus a Standard BTK Inhibitor in Patients with Mantle Cell Lymphoma
- A Pilot Study of 131-I Apamistamab and CAR T-Cell Therapy in People with Recurrent or Persistent Leukemia or Lymphoma
- A Study of CA-4948 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gilles Salles discloses the following relationships and financial interests:
-
AbbVie
Provision of Services -
Aptitude Health
Provision of Services -
Bayer
Provision of Services -
BeiGene, Ltd.
Provision of Services -
Bio Ascend
Provision of Services -
Bristol-Myers Squibb
Provision of Services -
Celgene
Provision of Services -
Epizyme
Provision of Services -
Everest Clinical Research Corporation
Provision of Services -
GenMab
Provision of Services -
Genentech
Provision of Services -
Gilead Pharmaceutical
Provision of Services -
Incyte
Provision of Services -
Ipsen
Provision of Services
-
Janssen Pharmaceuticals, Inc.
Provision of Services -
Loxo Oncology
Provision of Services -
Miltenyi Biotec Incorporated
Provision of Services -
MorphoSys AG
Provision of Services -
Nordic Nanovector ASA
Provision of Services -
Novartis
Provision of Services -
Owkin, Inc.
Ownership / Equity Interests -
Physicians' Education Resource
Provision of Services -
RAPT Therapeutics
Provision of Services -
Regeneron Pharmaceuticals, Inc.
Provision of Services -
Roche
Provision of Services -
Scientific Education Support Ltd.
Provision of Services -
Takeda Millennium
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].